Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Arimoclomol: a potential therapy under development for ALS.

Arimoclomol: a potential therapy under development for ALS. Expert Opin Investig Drugs. 2009 Dec; 18(12):1907-18.

View in: PubMed

Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.